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ABSTRACT

IN VITRO VISUALIZATION OF PEDIATRIC SIZED MECHANICAL HEART VALVE
PERFORMANCE USING AORTIC ROOT MODEL IN MOCK CIRCULATORY LOOP
By Sarah Brady Lederer, B.S. in Engineering

A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science
in Biomedical Engineering at Virginia Commonwealth University.

Virginia Commonwealth University, 2016
Director: Gerald E. Miller, Ph.D.
Professor, Biomedical Engineering

Congenital heart valve disease is one of the most common abnormalities in children, with
common valve defects being aortic stenosis, mitral stenosis, and valvular regurgitation. Although
adult sized mechanical heart valve (MHV) replacements are widely studied and utilized, there
are currently no FDA approved prosthetic heart valves available for the pediatric population.
This is due to a variety of reasons such as a limited patient pool for clinical trials, limited valve
sizes, and complex health histories in children. Much like adult sized mechanical heart valves,
potential complications with pediatric heart valve replacements include thrombosis, blood
damage due to high shear stresses, and cavitation. Due to pediatric sized MHVs being much
smaller in size than adult MHVs, different fluid dynamic conditions and associated
complications are expected. In order to accelerate the approval of pediatric sized heart valves for
clinical use, it is important to first characterize and assess the fluid dynamics across pediatric
sized heart valves. By understanding the hemodynamic performance of the valve, connections
can be made concerning potential valve complications such as thrombosis and cavitation. The
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overall objective of this study is to better characterize and assess the flow field characteristics of
a pediatric sized mechanical heart valve using flow visualization techniques in a mock
circulatory loop. The mechanical heart valve chosen for this research was a size 17 mm BjorkShiley tilting disc valve, as this is a common size valve used for younger patients with smaller
cardiovascular anatomy. The mock circulatory loop used in this research was designed to provide
realistic pediatric physiological flow conditions, consisting of a Harvard Apparatus Pulsatile
blood pump, venous reservoir, and a heart valve testing chamber. In order to expose the valve to
realistic pediatric flow conditions, six unique pump operating conditions were tested that
involved pre-determined heart rate and stroke volume combinations. In addition, a modified
aortic root model was used to hold the mechanical heart valve in place within the loop and to
provide more realistic aortic root geometry. This heart valve chamber was made from a
transparent acrylic material, allowing for fluid flow visualization. A traditional Particle Image
Velocimetry (PIV) experimental set up was used in order to illuminate the particles seeded
within the fluid path, and thus allowing for the capture of sequential images using a high speed
camera. The data collected throughout this study consisted of flow rate measurements using an
ultrasonic flow meter, and the sequential PIV images obtained from the camera in order to
analyze general flow characteristics across the pediatric valve. Such information regarding the
flow profile across the valve allowed for conclusions to be made regarding the valve
performance, such as average flow velocities and regions of regurgitant flow. By gaining a
better understanding of the fluid dynamic profile across a pediatric sized heart valve, this may
aid in the eventual approval of pediatric sized mechanical heart valves for future clinical use.
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1 INTRODUCTION

1.1 Motivation and Significance
Valvular heart disease is a life-threating condition that affects millions of people worldwide,
leading to approximately 250,000 heart valve replacements each year [1]. Although more
prevalent in the adult population, congenital heart valve disease is one of the most common
abnormalities found in children. Valvular heart defects in children can be seen on both the
systemic and pulmonary side of the heart, with the most common valve defects being mitral
stenosis, aortic stenosis, and valvular regurgitation [2]. Such structural valve abnormalities
adversely affect the blood flow across the diseased valve, and therefore affect blood flow
throughout the rest of the body. Congenital heart valve defects occurs in approximately 1 in 150
children, being one of the most common abnormalities present at birth [5]. As a child’s cardiac
anatomy is significantly smaller than that of an adult patient, pediatric valve replacement
presents unique surgical challenges for physicians and is often characterized as a high-risk
procedure. Commercially available heart valve prostheses are often too large for a child’s
anatomy, creating a variety of additional surgical complications. Typically an enlargement
procedure is performed in order to accommodate the prosthetic heart valve, which creates
additional risks of injury to adjacent cardiovascular structures [2].
Currently, there are no FDA approved mechanical heart valves suitable for the pediatric
population, and smaller sized commercially available valves are limited. The pediatric
population has been excluded from replacement heart valve clinical trials due to a limited patient
pool, complex health histories in children, limited valve sizes, and the need for additional valve
replacements throughout the lifetime of a study due to the rapid growth of a pediatric population
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[2]. As inappropriately sized pediatric valve replacements create additional complications, the
need for appropriately designed and approved pediatric sized valves remains a pressing challenge
in the medical device industry. In order to expedite the approval of appropriately sized pediatric
heart valves for future clinical use, knowledge of the fluid dynamics across the valve must first
be explored in order to assess the hemodynamic performance of pediatric sized heart valves.
1.2

Heart Valve Function and Anatomy
The human heart functionally serves as a pump, sending oxygenated blood and nutrients to

various areas of the body. The human heart consists of four chambers and four major valves. The
four chambers consist of the right atrium, right ventricle, left atrium, and left ventricle. The two
atrioventricular (AV) valves lie between the atria and the ventricles, consisting of both the mitral
valve and tricuspid valve. The mitral valve lies between left atrium and left ventricle, whereas
the tricuspid valve lies between the right atrium and right ventricle. The two semilunar (SL)
valves, the aortic and pulmonary valve, lie between the ventricles and the exit arteries allowing
blood to exit the heart. The primary function of the four heart valves is to ensure unidirectional
flow throughout the heart, playing a vital role in the overall performance of the heart and thus
blood supply throughout the body. A diagram of the four chambers and four valves can be
visually depicted in Figure 1.1.
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Figure 1.1: Heart Chambers and Valves
1.2.1

Right Heart Anatomy
The right side of the heart is responsible for transporting CO2 rich blood to the lungs.

Blood enters the right atrium via the superior and inferior vena cava, and then enters the right
ventricle via the tricuspid valve. The tricuspid valve contains three leaflets that are attached to
papillary muscles by chordae tendineae located in the right ventricle. The primary function of the
chordae tendineae is to provide stability for the tricuspid valve, using tension to prevent prolapse
of the leaflets into the atrium. During atrial systole, chordae tendineae are relaxed to allow the
movement of blood from the atria to the ventricle. During this phase, pressure is higher in the
atria than the ventricle, allowing blood to flow down the pressure gradient. During ventricular
systole, the tricuspid valve closes due to increased pressure in the chambers. The chordae
tendineae provide tension to the tricuspid valve during this phase in order to provide a tight
closed seal, preventing back flow of blood into the atrium.
During the systolic phase of the cardiac cycle, the right ventricle pumps blood through
the pulmonary arteries to the lungs via the pulmonary valve. Once the blood has entered the
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lungs, the blood undergoes a CO2-O2 gas exchange via diffusion mechanisms. The pulmonary
valve also contains three leaflets, and is opened due to the increased pressure in the right
ventricle during systole. The pulmonary valve then closes at the end of systole, when right
ventricular pressure begins to drop.
1.2.2

Left Heart Anatomy
The left side of the heart is the primary pumping mechanism responsible for systemic

circulation, allowing oxygenated blood to reach various tissues, muscles, and organs of the body.
Oxygenated blood enters the left atrium from the pulmonary veins, and is subsequently pumped
into the left ventricle through the mitral (biscupsid) valve [4]. In contrast to the tricuspid and
pulmonary valves of the right side of the heart, the mitral valve only contains two leaflets. The
orifice is surrounded by a ring of fibrous tissue, the annulus. Similarly to the tricuspid valve, the
mitral valve leaflets are connected to papillary muscles residing in the left ventricle. The mitral
valve opens due to increased pressure in the left atrium as it fills with blood. An initial surge of
blood enters the left ventricle and accounts for 70-80% of the total filling volume, whereas the
remaining 20% of blood volume results from atrial contraction. As the pressure in the left
ventricle increases due to filling, the mitral valve closes in order to prevent back flow. Due to the
left side of the heart experiencing a larger pressure gradient than the right side of the heart, and
therefore producing higher blood velocities, the mitral valve is typically the most common valve
to be replaced in adults [4].
Once pressure in the left ventricle surpasses pressure in the aorta, the aortic valve opens
and allows for blood to exit the ventricle and flow into the aorta. Once ventricular systole is
complete, pressure in the left ventricle quickly drops and allows for the closure of the aorta
valve. The aortic valve contains three leaflets; the right coronary, left coronary, and
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noncornonary leaflets. In contrast to the mitral and tricuspid valves, the aortic valve is directly
attached the vessel wall at the basal attachment and not supported by papillary muscle
attachments. Attachment of the three leaflets forms the annular ring, separating the aorta from
the left ventricle [1]. Superior to the annular ring is the aortic sinus, a structure containing three
bulges at the root of the aorta. During closure of the aortic valve, the unbound edges of the three
leaflets join together to form a seamless junction in order to prevent backflow, known as
coaptation.
To compensate for the heavier and nutrient-rich blood the left ventricle must push
throughout entire systemic circulation, the left ventricle muscle wall is much thicker in
comparison to the right ventricle. The mitral valve must withstand pressures up to 150 mmHg,
whereas the pulmonary and tricuspid valves must withstand pressures around 30 mmHg [1]. By
having a more dense muscle wall surrounding the left ventricle allows for the generation of more
physical pumping force from the left ventricle. Due to the difference in workload between the
right and left side of the heart, the left side of the heart experiences much higher forces and more
strenuous conditions. As a result, left sided heart valves are often more at risk for failure as they
undergo larger amounts of stress. Figure 1.2 displays left ventricular pressure, volume, aortic
pressure, and atrial pressure during phases of the cardiac cycle.
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Figure 1.2: Pressures and Volumes of Cardiac Cycle
1.3 Congenital Heart Valve Diseases
The most common heart valve defects in the pediatric population include aortic stenosis,
mitral stenosis, pulmonary stenosis, and valvular regurgitation. As mentioned previously,
congenital heart valve defects remains one of the most common abnormalities present in children
at birth. Typically, such defects are often associated with additional structural abnormalities that
may require additional surgical intervention [2]. The most common heart valve defect found in
the pediatric population is valvular regurgitation, which can affect the mitral, aortic, and
pulmonary valves. Valvular regurgitation is often caused by catheter-based or surgical
intervention aimed to treat severe valvular stenosis [1, 2]. Stenosis, or the narrowing of the native
valve, is also a common valve defect often seen in the pediatric population. Based on the
definitions provided in the June 2003 Pediatric Expertise for Advisory Panel [2], the pediatric
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population consists of newborns (birth to 1 month), infants (1 moto 1 yr), toddlers (1-4 yr),
children (5-12 yr), and adolescents (13-21 yr).
1.3.1

Aortic, Mitral, and Pulmonary Stenosis
Aortic stenosis involves the narrowing of the native aortic valve. This particular valve

defect affects approximately 6 of every 1000 babies born [12]. Aortic stenosis can occur as an
isolated defect, or in association with the aortic valve leaflets, ventricular septal defect, mitral
valve abnormalities, and less commonly with atrial septal defect [12]. Due to this narrowing of
the valve, the resistance of blood flow through the aorta is increased, generating a larger pressure
drop across the valve. Due to this increased resistance of blood flow, a lesser amount of blood is
able to pass through the aortic valve and to the rest of the body. Aortic stenosis in children can
range from mild, moderate to severe. For children diagnosed with aortic stenosis after birth,
appropriate treatment is determined by a variety of factors such as location of the narrowing,
severity, associated cardiac problems, age, and size [12]. Aortic stenosis in children can be
treated surgically or by balloon dilation, which will be further detailed in the following section.
Congenital mitral valve stenosis involves the narrowing and thickening of the mitral
valve, and is a very rare condition occurring in less than 4 out of 1000 infants with congenital
heart disease [13]. Mitral stenosis can occur at the supravalvular, valvular, or subvalvular levels.
Common associated cardiac abnormalities associated with mitral stenosis are aortic valve
stenosis and subvalvular aortic stenosis. Mitral stenosis obstructs blood from entering into the
left ventricle, causing left atrial pressure to rise in proportion to the severity of the narrowing. As
a result, this also restricts pulmonary venous return into the left atrium, increasing pressure in the
right side of the heart. Children diagnosed with severe forms of mitral stenosis are likely to
require surgical catheterization or valve surgery.
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Congenital pulmonary stenosis involves the narrowing and thickening of the pulmonary
valve, and accounts for approximately 10% of heart defects diagnosed during childhood [12].
Pulmonary stenosis can occur by itself or is conjunction with a variety of congenital heart defects
such as atrial septal defect or Tetralogy of Fallot. Due to the thickening of the pulmonary valve,
resistance to blood flow from the right ventricle to the pulmonary artery is increased. The
severity of narrowing is measured by the pressure difference across the affected area. The higher
the pressure difference indicates a higher degree of narrowing and the harder the right side of the
heart must work in order to deliver blood to the lungs. Mild pulmonary stenosis is when the
pressure difference is less than 30-40 mmHg, moderate pulmonary stenosis is when the pressure
is 40 to 60 mmHg, and severe pulmonary stenosis is when the pressure is greater than 60-70
mmHg [12]. Critical pulmonary stenosis is a term used in infants born with very severe
narrowing (greater than 90 mmHg) and requires treatment soon after birth.
1.3.2

Mitral Valve Prolapse
Although very rare during childhood, mitral valve prolapse (MVP) is diagnosed when

there is a backward bowing of the mitral valve leaflets into the left atrium as the ventricle
contracts. The leaflets are commonly thicker than normal functioning leaflets, and sometimes
mitral valve regurgitation is present. Mitral valve prolapse is often associated with connective
tissue disorders, such as the Marfan syndrome [12]. This particular disease can be inherited from
the child’s parents. There are usually minimal or no major symptoms related to MVP, however if
mitral valve leakage progresses over time surgical intervention or the use of antibiotics is
sometimes needed.
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1.3.3

Valvular Regurgitation

Valvular regurgitation or insufficiency occurs when a particular valve does not close
completely and allows blood to flow back into a particular chamber of the heart. Valvular
regurgitation is often reffered to as a “leaking” valve, allowing blood to flow in two directions
during contraction of the valve. Valvular regurgitation in children is commonly acquired due to
catheter-based or surgical intervention aimed at treating severe stenosis, and can occur in the
aortic, mitral, and pulmonary valves [2]. Isolated valvular regurgitation is a rare occurrence, as it
is commonly associated with valvular stenosis or a ventricular septal defect [14].Valvular
regurgitation due to surgical intervention is one of the most common valve defects within the
pediatric population.
When a valve becomes regurgitant, the heart must work increasingly harder in order to
compensate for the back flow of blood. In the case of mitral valve insufficiency, where blood
flows backwards from the left ventricle into the left atrium, the heart compensates by leading to
an increase in left ventricle ejection volume. When the regurgitant fraction of blood reenters the
left ventricle, the left ventricle experiences volume overload. The left ventricle compensates via
the Frank-Starling mechanism, resulting in an increased left ventricular stroke volume. Although
left ventricular stroke volume increases, total forward stroke volume typically decreases and
leads to lower cardiac output. These may lead to numerous complications including pulmonary
congestion, hypotension, and heart failure; depending on the severity and volume of the
regurgitant blood flow. Mitral valve insufficiency can be developed in three clinically significant
stages; acute, chronic compensated and chronic decompensated [29]. Figure 1.3 depicts acute
mitral regurgitation, and what immediately occurs with left heart pressure and volume, the stage
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in which the rergurgitant flow causes a sudden volume overload of the left atrium and left
ventricle.

Figure 1.3: Acute Mitral Regurgitation [29]
1.4 Treatment of Congenital Heart Valve Disease
Depending on the severity of the heart valve defect, congenital heart valve disease can be
treated using either catheter-based or surgical techniques. In some cases, both catheter based and
surgical techniques are used for an individual patient with severe valve defects. Treatment of
congenital heart valve disease using a catheter-based approach is desirable as it is easier on the
child than open-heart surgery. However, sometimes surgery is required for particular defects that
cannot be completely treated with catheter-based techniques. Figure 1.4 displays the distribution
of valvular surgical procedures performed at the Children’s Hospital in Boston, MA over a 5-
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year period, separating each procedure in regards to the valve treated and if the treatment
involved repair or replacement [2].

Figure 1.4: Distribution of Pediatric Valve Surgical Procedures [2]
1.4.1

Catheter-Based Techniques
Balloon Vavuloplasty is a common catheter procedure used to treat congenital valvular

stenosis, in order to restore the valve’s opening and closing abilities. During this procedure, a
catheter with a balloon at the tip is threaded through a blood vessel in order to reach the diseased
valve. The balloon is then inflated in order to facilitate the opening of the valve. After the valve
has successfully been dilated, the balloon is deflated and both the balloon and the catheter tube
are removed from the patient [6]. This method is currently the most commonly used method to
treat congenital heart valve stenosis, as it is less invasive than surgical intervention. However,
this technique carries the risk that the treated valve will later become regurgitant and require
additional surgical intervention [2]. As a result, this procedure is viewed as a sufficient mid-term
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solution, however should not be considered a life-long solution to heart valve abnormalities in
children.
1.4.2

Surgical Valvotomy
An additional treatment option for children with severe valvular stenosis is direct incision

of the fused leaflets of the valve during open-heart surgery [12]. During this procedure, a midline
sternotomy incision is made down the middle of the chest and a heart-lung machine is used to
support the patient while the valve is being repaired. This procedure is commonly performed
when there is severe narrowing of surrounding structures in addition to the valve itself, often
present above or below the valve. In such cases, a patch may need to be used to enlarge narrowed
regions in addition to valve repair [12]. Mild residual narrowing and minimal valve leakage may
occur, but oftentimes does not result in long-term problems. However, this approach is
significantly more invasive than catheter techniques, which may lead to additional surgical
challenges when operating on small children.
1.4.3

Ross Procedure
In the case of very young children and infants, balloon valvuloplasty and valve

replacement prove to be extremely difficult for a variety of reasons [8]. As a result, the Ross
Procedure is sometimes the recommended procedure for small infants. This procedure involves
replacing the aortic valve with the patient’s own pulmonary valve, and using a pulmonary
allograft to replace the removed pulmonary valve [7]. This procedure is commonly used to treat
aortic stenosis in infants and children. The advantages of using this procedure include growth
potential, optimal hemodynamic performance, no need for anticoagulation medication, and less
risk for hemolysis. However, some of the major concerns surrounding this procedure is the
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potential dilation of the autograft, need for reoperation, and replacement of right ventricular
outflow tract conduits [7]. In addition, this procedure aims to treat a single valve defect with a
two-valve procedure, providing additional surgical demands and risks. Figure 1.5 visually
depicts the Ross Procedure.

Figure 1.5: Ross Procedure

1.4.4

Valve Replacement
In the case where a diseased heart valve cannot effectively be treated with catheter-based

or surgical techniques, the faulty valve may need to be replaced with either a mechanical or
bioprosthetic heart valve. This often occurs when the diseased valve is too narrow or too leaky to
surgically repair. Valve replacement in children is often viewed as a last resort, as both
mechanical and bioprosthetic heart valves bring with them specific risks. Although mechanical
heart valves prove very durable, thrombosis and the need for additional replacement as the child
becomes older presents several disadvantages. Bioprosthetic heart valves offer the advantage of
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superior hemodynamic performance, however the risk of calcification may also lead to the need
for additional replacement. One of the major drawbacks to both mechanical and bioprosthetic
valve replacement in children is the limited range of valve sizes available for the pediatric
population.
1.4.4.1 Mechanical Heart Valves
Mechanical heart valves consist of three main elements; an occluder, the housing, and a
sewing ring for proper implantation. There are three major mechanical heart valve
classifications: caged-ball, tilting disc, and bileaflet valves. Mechanical heart valves come in a
variety of sizes, however are mostly studied and utilized within the adult population. There are
some smaller valve sizes available (17-19mm), however these sizes are not suitable for infants
and very small children [9]. Although mechanical heart valves have experienced wide usage in
adult patients, there still remains a limited number of pediatric-sized valves and there is currently
no FDA-approved pediatric sized mechanical valve [1].
As there are limited available pediatric mechanical heart valve sizes, the available
prosthesis chosen by the physician is often too large for the child’s anatomy. This may result in
delay in referral for surgery, as well as additional surgical techniques in order to enlarge the site
of implantation to accommodate the prosthesis [1, 2]. Such enlargement procedures include the
Nicks procedure, the Manougian procedure, and the Konno procedure, all of which involve
annular enlargement [9]. Specifically, these procedures involve enlarging the left ventricular
outflow tract and the valve ring by preforming an incision into the outflow tract of the right
ventricle and the septum or wall between the right and left ventricles [12]. In addition,
mechanical heart valves in children (and adults) require life-long anticoagulation medication to
prevent thrombosis with its inherent risk of bleeding.
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1.4.4.1.1 Caged-Ball Valves
The first successful mechanical heart valve implanted in a patient was developed by
Hufnagel in 1952, consisting of a caged ball design [15]. This design gave way to the
development of the Starr-Edwards aortic and mitral ball valves in the 1960s, with this design still
currently being used clinically in the adult population. The housing of this caged valve is made
from Stellite (a metal alloy of cobalt, chromium, molybdenum, and nickel), and the ball is made
from Silastic Rubber (silicone rubber) [15]. The Starr-Edwards caged ball valve demonstrates
®

good reliability but poor hemodynamic performance. The flow goes through the annulus and
around the silicone rubber ball, forming a circumferential jet that separates from the ball [1]. The
caged ball valve produces a large pressure drop due to the high profile of the ball, in comparison
to that of both tilting disc and bifleaflet valves. Due to caged-ball valves having a relatively large
profile, they are not typically used for mechanical heart valve replacement within the pediatric
population.
1.4.4.1.2 Tilting Disc Valves
Following the development of the caged-ball valve, the single leaflet tilting disc valve
was developed in 1969 by Bjork-Shiley. This valve consists of a single pyrolytic carbon disk that
is stabilized by inflow and outflow metal alloy struts. This design demonstrated improved
hemodynamics, as the single disc serves as a partial occluder to flow rather than central
occlusion produced by the caged-ball valve. Currently, the most common tilting disc valve used
in the adult population is the Medtronic-Hall tilting disc valve, which consists of a titanium
frame and a pyrolytic carbon disc. During systole, two high velocity jets flow from both the
major and minor orifice outflow regions [1]. The flow on each side of the strut is almost
symmetric, demonstrating very similar structural organization and velocities. Tilting disc valve
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designs often demonstrate lower regurgitant volumes than bileaflet designs, with smaller valves
demonstrating lower regurgitant volumes. Leakage flow through the gap between the disc and
the housing of the valve often produces jets, which prove useful in the potential washing of the
gap region [1]. This washing effect minimizes the formation of thrombosis around the gap region
of the tilting disc valve. Although most tilting disc valves are designed for the adult population,
there are some smaller sizes available (17-19mm) that are sometimes used for younger patients.
1.4.4.1.3 Bileaflet Valves
In the late 1970s, bileaflet valves composed of pure pyrolytic carbon-based leaflets were
introduced. The bileaflet valve designs currently being used today consist of the St. Jude Medical
bileaflet valve, Carbomedics bileaflet valve, and the On-X valve. These designs differ in the
design of the hinge mechanism and the opening and closing angle, however both consist of
pyrolytic carbon housing and leaflets, and a Dacron sewing ring. The bileaflet valve has become
the gold standard of mechanical heart valves for most surgeons due to its favorable
hemodynamic performance and anti-thrombogenic characteristics [15]. The St. Jude bileaflet
valve, the more popular of the two designs, consists of a washout effect as the blood flows across
the space between the leaflets, reducing the possibility of blood clot formation in those areas of
the valve. The forward flow of a bileaflet valve is characterized by a triple-jet pattern, with two
lateral orifices and one central orifice. After traveling approximately 20-30 mm downstream (for
a 27 mm sized valve) the three jets merge into a central flow region [1]. Figure 1.6 displays the
three major classes of MHVs currently being used.
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Figure 1.6: (From Left to Right) Starr-Edwards Caged-Ball Valve, Medtronic Tilting
Disc Valve, St. Jude Bileaflet Valve
1.4.4.2 Bioprosthetic Heart Valves
Bioprosthetic valves are replacement valves derived from either animal or human heart
tissue, and have also been used as an option for valve replacement in children. Bioprosthetic
valves come in a variety of sizes and types, however sizes under 19 mm are unavailable. As a
result, bioprosthetic valves are not suitable for small children and infants even if enlargement
techniques are used [9]. As bioprosthetic valves more closely match the anatomy of a native
heart valve than a mechanical heart valve, their hemodynamic performance is often superior to
that of mechanical heart valves. As a result, thrombosis is less of an issue with bioprosthetic
valves and the patient is not required to be on anticoagulants. However, calcification of available
bioprosthetic valves remains a major issue and may lead to the need for reoperation. The
occurrence of calcification in porcine bioprostheses and autologous pericardia is higher in
children than in adults, which accounts for the poor durability such valves present in regards to
pediatric applications [10]. As with mechanical heart valves, there is a limited pool of available
bioprosthetic heart valves suitable for the pediatric population.

18	
  
	
  

1.5 In-Vitro Fluid Mechanics of Mechanical Heart Valves
Many of the complications that arise with mechanical heart valves are often associated with
the fluid mechanics of particular valve designs. Therefore, there is a need to evaluate valve
performance through in-vitro studies that aim to recreate the physiological conditions valves
undergo within the body. From an engineering perspective, the ideal heart valve should 1)
produce minimal pressure drops across the valve, 2) produce relatively small regurgitation
volumes, 3) minimize turbulence, 4) minimize regions of high shear stresses, and 5) not create
stagnation of flow separation regions in the flow fields in its immediate vicinity [1]. All such
factors can be investigated in in-vitro experimental set ups in order to better assess a particular
mechanical heart valves’ viability in-vivo.
A pressure drop is a measure of flow potential energy losses that occur when viscous blood
flows through a heart valve, and is an indication of heart valve efficiency [1]. A mechanical heart
valve design should not significantly restrict the flow of blood, thus should produce a minimal
pressure drop across the valve. The effective orifice area (EOA) and performance index (PI) are
indices of how successfully a valve uses its primary or internal stent orifice area. The EOA is
defined as [1]:
!"# =

!!"#
51.6 ∆!

where !!"# represents the root mean square systolic/diastolic flow rate and ∆!  represents the
mean systolic/diastolic pressure drop. A larger value of a valve’s EOA indicates a smaller
pressure drop, and therefore a smaller energy loss. The performance index (PI) is also a
measurement of a valve’s resistance to forward flow, and is represented as the ratio of the EOA
to the valve’s sewing ring area [1]. Thus, the PI normalizes EOA by the valves size.
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Regurgitation in mechanical heart valves occurs from reverse flow during valve closure and
leakage, and is typically measured by percentage of stroke volume. Regurgitant volume is
represented as the sum of closing volume and leakage volume, with closing volume being the
total volume of retrograde flow during valve closure and leakage volume represents any fluid
accumulation after valve closure. The amount of regurgitant volume depends on both valve type
and size, increasing as valve diameter increases [1]. It is common for mechanical heart valves to
display larger amounts of regurgitation as opposed to bioprosthetic valves. Although major
valvular regurgitation may cause complications, minor regurgitation is sometimes desirable in
certain valve designs in order to produce washout effects.
Other important fluid mechanics parameters that determine a valves performance are flow
velocities and regions of shear stress in both immediate vicinities of the valve as well as within
the valve. Flow field characteristics and shear stress regions vary depending on valve type and
size, presenting the need to investigate fluid mechanics behavior in in-vitro studies prior to
clinical use. Both flow fields and areas of high shear stress are often attributed to valve
complications, such as thrombosis and hemolysis. Regions of flow stagnation and/or separation
have been connected to thrombus formation, tissue overgrowth, and calcification [1]. Regions of
high shear stress may lead to damage to red blood cells such as hemolysis, as well as platelet
activation. Therefore, flow velocities and regions of shear stress are two major parameters to be
studied when analyzing the fluid dynamics of a mechanical heart valve.
Another fluid characteristic of mechanical heart valves is the occurrence of cavitation, which
is defined as the formation of vaporous or gaseous bubbles caused by a local pressure drop and
their following collapse when pressure is recovered [34]. Some of the factors associated with
MHV cavitation include valve closing velocity, ventricular loading rate, squeeze flow, valve
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mounting, and occluder material properties. When the bubbles collapse after pressure has been
recovered, high velocity fluid jets and pressure waves are produced which are capable of causing
blood and valve material damage. Valve material erosion and pitting damage due to cavitation
has been reported in many in-vitro studies, as well as blood damage such as hemolysis has been
reported in in-vitro and in-vivo studies [34]. Therefore, minimizing the occurrence of cavitation
remains a top priority in the development of mechanical heart valves.
1.5.1

Clinical Complications Related to Fluid Mechanics of MHVs
One of the major clinical complications associated with mechanical heart valve fluid

behavior is the initiation of thrombosis around various valve components, which can be
attributed to both the hemodynamic profile of the valve as well as the valve material. Since this
study is focused on fluid dynamics, this review will omit the relationship between clinical
complications and valve material. The initiation of a thrombotic event involves a complex set of
protease reactions involving roughly thirty unique coagulation proteins [33]. The final outcome
of these reactions is the conversion of fibrinogen, a soluble protein, into insoluble strands of
fibrin through an active enzyme thrombin [33]. In conjunction with activated platelets, the fibrin
strands form a stable blood clot. The complex geometrical designs and dynamic opening and
closing behavior of MHVs can result in non-physiological flow conditions that may bring arise
to turbulence, vortices, stagnation, and flow separation. Such flow phenomena produce high
local shear stresses that can lead to the activation of platelets and some coagulation proteins,
resulting in thrombus formation in localized regions of the valve. Some research has shown that
the Von Williebrand Factor (VMF), a large blood glycoprotein, plays an important role in the
shear-induced platelet activation [33]. Specifically, several studies have shown that the shear-
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mediated conformational changes of VMF facilitates its binding to platelets, eventually leading
to thrombus formation in local regions of high shear stress within the valve [33].
In addition to thrombosis of MHVs, hemolysis is also a major clinical complication
associated with the fluid mechanics behavior of MHVs. As early as 1970, Harker and Slicther
[22] showed that patients with mechanical heart valves exhibited a shortened platelet half-life
caused by platelet activation and destruction. Mechanical trauma caused by the valve structure
itself as well as high shear stresses caused by flow turbulence are both viable causes for such
destruction of red blood cells and platelets. Due to the nature of flow across a MHV, the flow can
be characterized as very complex and highly unsteady, and at times turbulent. Such flow
behaviors brings arise to a variety of clinical complications, such as thrombosis and hemolysis,
therefore it is important that sophisticated experimental and computational techniques are used in
order to test the viability of a particular mechanical heart valve design.
1.5.2 History of In-Vitro Evaluation of Mechanical Heart Valves
Dating back to the 1970s, investigations of the fluid mechanics of MHVs have been
conducted in order to better assess the performance of a wide variety of MHVs. Such studies
have used varying experimental setups and have tested both FDA-approved and unapproved
valve designs. Some of the major topics focused on in such studies include regurgitant flow
behavior, vortex and microbubble formation, valve closure, cavitation potential, as well as
investigating the flow region near the hinges of certain valves. Such research has provided useful
information regarding MHV performance and design and has led to the development of many
MHV designs. This section of this paper will review the history of experimental studies of
prosthetic heart valve flow dynamics.

22	
  
	
  

In 1975, Brown et al [16] conducted one of the first experiments that investigated the
relationship between thrombus formation and shear stress, one of the major complications
associated with MHVs of all types. From this study, they found that platelets exposed to shear
stresses over 50 dyne cm-2 release a larger amount of ADP and had a tendency to aggregate
faster than platelets exposed to lower values of shear stress [16]. This finding showed that shear
stress could induce platelet aggregation, which may led to the damage of surrounding red blood
cells. Therefore, identifying regions of high shear stress within the flow pattern across a MHV
has remained a major topic of interest when investigating fluid behavior of MHVs.
Laser Doppler Velocimetry (LDV) is an experimental technique involving the use of the
Doppler shift in a laser beam in order to measure the velocity in transparent fluid flows, and has
been used extensively in the investigation of MHV fluid dynamics. Using 1D LDV, Chandran et
al [17] investigated flow fields distal to that of caged ball and tilting disc aortic valves. They
concluded that both the velocity profiles and turbulent shear stresses downstream from the tilting
disc valve were directly dependent on the opening behavior of the valve. Additionally, they
concluded that the turbulent shear stresses downstream the caged ball valve were smaller in
magnitude than that of the tilting disc valves. Using 2D LDV, Yoganathan et al [18] developed a
detailed study of the pulsatile forward flow fields of both the St Jude Bileaflet valve and the
Bjork-Shiley tilting disc valve. Their results indicated maximum shear stresses of 1200 dynes
cm-2 for the bileaflet valve and 2000 dynes cm-2 for the tilting disc valve. Using 3D LDV,
Fontaine et al [19] studied the flow fields of both Bjork-Shiley and St. Jude bileaflet valves, and
produced results very similar to that of 2D LDV studies (values within 10-20%).
Another major topic that has been widely investigated through in-vitro studies of MHVs
is the occurrence of retrograde flow across the valve. Although most MHVs are deliberately
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designed to include some degree of retrograde flow in order to wash out certain areas of the
valve, regurgitant flow has also been attributed localized regions of high shear stress and vortex
formation. Yoganathan et al [18] found that the peak reverse velocity through a Medtronic-Hall
tilting disc valve was 0.28 ms-1 with a peak shear stress of 680 dyne cm-2 under pulsatile aortic
conditions. Meyer et al [20] showed that leakage flows are capable of producing turbulent jets
with elevated Reynolds shear stresses even in bileaflet valves, with maximum regurgitant
velocities ranging from 0.7 to 2.6 m/s and maximum shear stresses ranging from 450 to 3,600
dyne cm-2 after valve closure. Their results allowed them to predict regurgitant leakage flow
regions with different MHV designs, identifying that the hinge region of bileaflet valves are the
principle site of leakage whereas the gap between the disk and the support ring is the principal
site of leakage for tilting disc valves [20]. Identifying the regions and magnitude of leakage for a
particular MHV, can lead to the development of improved designs that may offer more favorable
hemodynamic performance.
The investigation of valve closure dynamics and associated cavitation potential began in
1989, when clinical failures of Edward-Duromedics valves were reported [22]. These valves
were noted with both pitting and erosion features, indications of mechanical cavitation damage.
Cavitation is the process of both the growth and collapse of vaporous and gaseous bubbles in a
liquid, and is often caused by a sudden pressure drop often attributed to valve occluder closure.
When such bubbles collapse, micro-jets may form and cause localized erosion damage to
occluder material as well as blood damage. There are many additional factors that influence
MHV cavitation, including ventricular loading rate, squeeze flow, valve mounting, and occluder
material properties [21, 22]. The evaluation of cavitation near MHVs has primarily been focused
on visualization of bubble formation in transparent media, however recent studies have shown
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more quantitative methods of evaluation. Lamson et al [21] presented a study in which MHV
cavitation patterns were detected in real time. By using a real time detection process, they were
able to develop a cavitation cycle that corresponds to a normal cardiac cycle. Such studies have
led to the exploration of the both the causes and locations of MHV cavitation, which aids in the
development and design of MHVs.
1.5.3

Mechanical Heart Valve Experimental Setups
In order to achieve reliable data concerning mechanical heart valves, an effective

simulation of the native heart environment must first be achieved. In order to do so, a typical
experimental set up consists of a mock circulatory loop to simulate appropriate flow conditions
in addition to a valve holding chamber and image capture system. Depending on the intended
goal of a particular experiment, both the design of the mock loop and valve chamber may vary.
For instance, some studies may choose to focus on reproducing specific flow conditions whereas
some studies may choose to focus on anatomical correctness. The following section will discuss
some of the valve testing chambers and mock loops that have been used and their purpose in that
particular study.
1.5.3.1 Mechanical Heart Valve Testing Chambers
As mentioned previously, MHV experimental set up is largely focused on the particular
intent from the study. For instance, Browne et al [23] focused on investigating turbulent flow
downstream of a St. Jude bileaflet valve using both laser Doppler velocimetry (LDV) and
Particle Image Velocimetry (PIV), and comparing the two imaging modalities. Since this
particular study focused more on the comparison of the two imaging techniques, compliance and
peripheral resistance were neglected. Their main focus was effectively imaging downstream of
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the valve, therefore their MHV testing chamber consisted of a clear, anatomically correct aortic
root model. The aortic root model was made from a solid acrylic block, and incorporated a
native sinus section. Figure 1.7 displays the aortic root model used in this study.

Figure 1.7: Aortic Root Model
Manning et al [24] sought to investigate the regurgitant flow field characteristics of a St.
Jude bileaflet valve both in localized regions within the valve and in regions distal to the valve.
This particular study utilized a “single shot” chamber system which consisted of a transparent
two compartmental box in order to mount the valve in the mitral position. The larger component
represented the left atrium and was open to the atmosphere, whereas the smaller component
represented the ventricle and was sealed and connected to pneumatic pressure regulator system.
This particular system simulated the reverse flow characteristics of the cardiac cycle with
minimal forward flow through the valve, allowing better investigation of regurgitant
characteristics. An anodized aluminum valve holder was placed between the two chambers in
order to hold the valve in place throughout the duration of the study. Figure 1.8 visually depicts
the “single shot” chamber system used in this particular study.
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Figure 1.8: “Single Shot” Chamber System
Manning et al [25] later went on to investigate the near valve flow characteristics of a
Bjork-Shiley tilting disc valve using a modified version of the “single shot” chamber system.
The aim of this particular study was to better understand the local fluid mechanics that occur
during MHV closure and rebound, including the influence of the regurgitant jet and its
relationship to cavitation. Since this particular study focused on near-valve flow characteristics, a
modified single shot chamber with more realistic near valve geometry was used. This modified
chamber included a more confined expansion/contraction on either sides of the valve,
representing the sinus area. Although this approach was not completely anatomically correct, it
provided a more realistic restriction to flow found in the native left atrium and ventricle. This
particular chamber only simulated the closing phase of the MHV, as that was the primary focus
of this study. Figure 1.9 shows the set up for the modified single shot chamber.
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Figure 1.9: Modified “Single Shot” Chamber
1.5.3.2 Mock Circulatory Loops
Mock circulatory loops have been extensively used for the in-vitro testing of various
cardiovascular devices, a critical process necessary prior to clinical trials of any medical device.
Mock circulatory loops are designed to represent the human cardiovascular system to allow for
the testing of artificial heart valves, ventricular assist devices (VADs), total artificial hearts, and
other cardiovascular devices. More basic systems consist of a pre-load chamber to produce a
constant flow and a resistance valve to alter the pressure drop [26]. Newer systems may involve
pulsatile flow, adjustable compliance and resistance, and other cardiovascular components. The
design and implementation of a mock circulatory loop is heavily dependent on the researcher’s
aim of their particular study.
Many of the earliest mock circulatory loop designs were pulse duplicators driven by
steeping motors and linear actuators. Based on a larger design proposed by Davila, Trout,
Sunner, and Glover in 1956, Bjork et al [27] introduced a pulse duplicator capable of controlling
systolic-diastolic ratio, stroke volume, and cardiac output in order to test mitral and aortic
prosthetic valves. The pulse duplicator consisted of two independent hydraulic systems; 1) a
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pumping system consisting of a one-armed roller pump capable of regulating stroke volume and
pulse rate and 2) a testing system capable of representing the left ventricle, aorta, peripheral
resistance, and the left atrium. The results of this study showed the importance of simulating left
ventricular, atrial, and aortic dynamics during the testing of prosthetic valves. Due to the success
of this study, many future studies involving the testing of prosthetic valves employ very similar
mock loop configurations. Figure 1.10 displays a schematic drawing of the pulse duplicator used
in this study.

Figure 1.10: Pulse Duplicator. LA=left atrium, MV= mitral valve, LV = left ventricle, P = pump,
AV = aortic valve, Ao = Aorta, PR = peripheral resistance, A = elastic container.
Overtime, other mock circulatory system designs were proposed that contained additional
cardiovascular elements to provide a more realistic physiological environment to test cardiac
devices. The Pennsylvania State University Mock Circulatory Loop System described by
Rosenberg [28] added new components such as waveform generators, compliance chambers to
stimulate arterial and venous compliance, systemic resistance elements, and a venous reservoir.
This system was initially designed in 1971 for the testing of ventricular assist devices, however
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has also been modified for the testing of mechanical heart valves. In addition, this system
implemented pressure transducers and flow meters in order to better monitor and assess the fluid
flow throughout the system. Figure 1.11 shows a diagram of the Penn State Mock Loop used for
the testing of an Electric Ventricular Assist Device.

Figure 1.11: Penn State Mock Circulatory System
1.5.4 Pediatric Heart Valve In-Vitro Studies
Adult mechanical heart valves have been widely studied and analyzed, through both invitro and in-vivo studies. By using flow visualization techniques, such as Particle Image
Velocimetry (PIV), the flow field characteristics of adult sized mechanical heart valves are well
characterized. The characterization of flow dynamics is essential in determining the effectiveness
of a mechanical heart valve, as flow features are often associated with heart valve complications
such as thrombosis. In one pediatric study, it was concluded that thrombosis is the second most
common problem of mechanical heart valves in children [11]. As pediatric sized heart valves are
smaller in size, this may result in for increased blood damage due to different fluid dynamic
conditions. Although there has been many in-vitro studies investigating the fluid dynamic
conditions for adult valves, there remains minimal research regarding pediatric heart valve fluid
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dynamics. Most studies focusing on pediatric valves have been limited to computational studies,
therefore excluding in-vitro experimental studies.
1.5.4.1 Computational Studies
Although there has not been many in-vitro studies focusing on pediatric heart valves,
there has been several attempts to analyze the fluid dynamics of pediatric valves using computer
simulation. Specifically, Yoganathan et al [3] modeled a pediatric sized valve and flow
conditions in order to assess blood damage in a bileaflet mechanical valve in 2014. In this
particular study a model of an adult-sized 23 mm St. Jude Medical Regent valve is selected for
the simulation, which is then scaled down in size to match the anatomy of both a 5-year old child
and 6-month old infant. A previously validated lattice-Boltzmann method was used to stimulate
pulsatile flow with thousands of suspended platelets for cases of adult, child, and infant flows
[3]. The blood used in this particular study was modeled as an incompressible Newtonian fluid,
and was modeled to have the same kinematic viscosity parameters as whole blood. The overall
aim of this study was to gain a better understanding of the hemodynamics and blood damage
performance of pediatric sized valves, which may help facilitate the approval of such valves to
be used in children.
The results of this particular computational study exposed several differences in both the
flow conditions and blood damage performance for the adult and child/infant simulations. Most
notably, it was observed that adult flow showed more disorganized small-scale flow features at
peak flow rates, whereas child and infant flow were characterized by larger, more coherent flow
with weak recirculation [3]. With infant flow, no vortex wakes were observed however the flow
was dominated by triple jet-like flow. In addition, infant flow showed much higher shear stresses
than the adult case, which can be attributed to the coherent forward jets observed with the infant
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flow. Platelet damage in the pediatric cases was higher than the adult case, indicating possible
thrombus risks of pediatric valve flows. The highly damaged platelets overserved in the pediatric
flow were often found downstream of the valve, as there was less recirculation in the pediatric
flow cases. The differences between both the adult and pediatric cases from this study point out
the need to further investigate flow properties of pediatric valves, and may push for the eventual
approval of prosthetic valves for the pediatric population.
1.6 Research Aims
Congenital heart valve disease is one of the most common abnormalities in children, with
common valve defects being aortic stenosis, mitral stenosis, and valvular regurgitation [1].
Although adult sized mechanical heart valve (MHV) replacements are widely studied and
utilized, there are currently no FDA approved prosthetic heart valves available for the pediatric
population. Much like adult sized mechanical heart valves, pediatric sized MHVs may
experience potential clinical complications such as thrombosis, blood damage due to high shear
stresses, and cavitation. Due to pediatric sized heart valves being much smaller than adult sized
valves, different fluid dynamic conditions and associated complications are expected. In order to
accelerate the approval of pediatric sized heart valves for clinical use it is important to first
characterize and assess the fluid dynamics across the valve. By understanding the hemodynamic
performance of the valve, connections can be made concerning potential valve complications
such as thrombosis and cavitation. The overall goal of this study is to better characterize and
assess the flow field characteristics of a pediatric sized mechanical heart valve using flow
visualization techniques in a mock circulatory loop.
Although there have been many in-vitro flow field visualization studies for adult sized
MHVs, there remains a very limited number of in-vitro and computational studies devoted
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towards pediatric sized valves. Mock circulatory loops are often used to replicate the human
circulatory system in order to assess the functionality and hemodynamic performance of a MHVs
and other cardiac assist devices. By using flow visualization techniques, a better understanding
of the fluid dynamics across a valve can be achieved and used to assist in future MHV design.
This particular study intends to characterize the fluid dynamic performance of a pediatric sized
MHV through the implementation of a valve testing chamber in a mock circulatory loop using
appropriate physiological conditions, as there are a very limited number of studies that focus on
pediatric sized valves. By gaining a better understanding of the fluid dynamic profile across a
pediatric sized heart valve, this may aid in the eventual approval of pediatric sized mechanical
heart valves for future clinical use.
Specific Aim #1: Modify existing mechanical heart valve chamber in order to accommodate a
pediatric-sized mechanical heart valve.
Specific Aim #2: Implementation of valve holding chamber into mock circulatory loop under
appropriate pediatric physiological conditions.
Specific Aim #3: Characterize flow field dynamics using flow visualization techniques in order
to assess valve performance in regards to potential complications such as thrombosis and
cavitation.
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2 METHODS AND MATERIALS
2.1 Mock Circulatory Loop
In order to test and analyze the flow conditions across a mechanical heart valve, it is
necessary to implement a mock circulatory loop system that is capable of simulating the human
circulatory system. Therefore, a mock circulatory loop similar to that of previous cardiovascular
research was used throughout this study. This particular mock loop consists of several key
components; including a Harvard Apparatus Pulsatile Blood Pump to serve the functional role of
the heart, a tank to serve as the venous reservoir, quick disconnect mechanisms, and a custom
aortic root model to hold the valve. Each of these components play a critical role in replicating
the human circulatory system, and can be adjusted accordingly to account for different
physiological conditions, such as pediatric flow conditions. These components are connected
with 1 ¼ inch outside diameter (OD) and ¾ inch inside diameter (ID) tubing that serves as the
native vasculature. In order to measure certain circulatory parameters, several devices are
installed throughout the system. With the expectation of the custom pediatric sized heart valve
chamber modification, the design the implementation of the mock loop system were completed
by Charles Taylor among other members of the Artificial Heart Laboratory at Virginia
Commonwealth University [30]. Figure 2.1 displays an image of the entire mock loop used in
this study with labeled components.
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Figure 2.1: Mock Circulatory Loop
2.1.1 Venous Reservoir
The venous reservoir, which is represented as a 6” x 6” x 6” acrylic box, serves as the
supply for the Harvard Apparatus pulsatile pump. The venous reservoir consists of a top open to
the air, one inlet port and two outlet ports (Outlet Ports 1 and 2). The venous reservoir is open to
the atmosphere to allow for the evaporation of trapped air within the system, allowing for the
absence of bubbles throughout the tubing of the loop. The absence of air bubbles within the
system allows for more accurate flow measurements and more reliable PIV images. Outlet Port 1
leads to the inlet of the pulsatile pump, whereas Outlet Port 2 may lead to the inlet of a
ventricular assist device, when applicable. The tank is filled to a level just above the inlet port, to
ensure the loop is completely filled and bubbles are absent from the system. By making
adjustments to the fluid level in the tank and/or the height of the tank itself, the arterial pressure
of the entire system can be varied accordingly. A magnetic stir bar is placed in the venous
reservoir to ensure a homogenous mixture of the water/glycerin fluid. Figure 2.2 displays an
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image of the venous reservoir used in this research, with fluid being filled to just above the outlet
ports.

Figure 2.2: Venous Reservoir
2.1.2 Quick Disconnect Mechanisms
In between each outlet port of the venous reservoir and their respective connection, lie
quick disconnect mechanisms. These mechanisms serve as flow facilitators throughout the entire
mock loop, and allow for detachment of individual loop components without having to drain the
entire system. Each mechanism consists of a metal on metal cam-and-groove hose coupling in
conjugation with a low pressure PVC dual ball valve. By having such mechanisms in place,
modifications to the loop configuration can be made with relative ease and minimal disturbance
to the overall system. Figure 2.3 displays an image of the quick disconnect mechanism used in
this research.
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Figure 2.3: Quick Disconnect Mechanisms
2.1.3 Harvard Apparatus Pulsatile Pump
As mentioned previously, Outlet Port 1 of the venous reservoir tank serves as the inlet to
a Harvard Apparatus Pulsatile Blood Pump Model 1423. This particular pump is a well-respected
standard in hemodynamic research that aims to stimulate large animal cardiovascular systems.
This pump intended to pump blood or blood analog with minimum damage to blood cells, which
is ideal in hemodynamic research [32]. This particular pump consists of a mechanically activated
piston that oscillates within a transparent cylindrical hub, and two caged ball valves located at
the mitral (inlet) and aortic (outlet) positions, which can be seen in Figure 2.4. The valve cages
and liquid pathway have been designed to provide a streamlined flow absent of sharp edges,
minimizing hemolysis. All components of the liquid pathway of the pump can be disassembled
and sterilized when necessary.
With this particular pump, both stroke volume (SV) and strokes per minute (Heart Rate,
HR) can be dynamically adjusted while the pump is being utilized. The stroke volume is adjusted
using a knob on the top of the pump, with the actual stroke volume read out coming from a
calibrated plate on the side of the pump. The stroke volume can be adjusted from 15 mL to 100
mL. The strokes per minute, or “heart rate” can be adjusted using a dial on the end of pump
opposite from the pump head. The strokes per minute can varied from 10 to 100 strokes per min
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(BPM). In addition, this particular pump model is equipped with a control to adjust the ratio of
systole to diastole (systolic duration or output phase ratio). This control is located adjacently to
the rate control knob. The control is continuously variable from 25/75 to 50/50. In the 25/75
position, systole takes place 25% of the cardiac cycle while diastole takes place in 75%. By
having control of stroke volume, heart rate, and systolic duration, this pump is capable of testing
a wide range of physiological conditions.
In order to accommodate the testing of the pediatric valve farther downstream to
represent the aortic positon, additional pump modifications performed in this research include
the removal of the silicon ball in the outlet pump valve. The design of the pump allows for easy
removal of such components, making it possible to remove the silicone ball-check valve.

Figure 2.4: Harvard Apparatus Blood Pump [32]
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2.1.4 Mechanical Heart Valve Testing Chamber
In order to visualize the flow across the heart valve, a modified version of an aortic root
model previously developed by Charles Taylor [31] was used to mount the pediatric sized valve
within the mock circulatory loop. The model is made entirely from transparent acrylic material,
allowing for the visualization of flow patterns surrounding the valve. The geometry of this model
was made by using female thorax cyro-slice datasets provided the Visible Human Project, in
order to provide more realistic and accurate aortic root geometry [31]. This particular aortic root
model was originally intended to house a 27 mm Bjork-Shiley Convexo-Concave tilting disc
valve, therefore additional modifications were needed in order to accommodate the smaller sized
heart valve. The valve selected for this study is a 17 mm Bjork-Shiley Convexo-Concave tilting
disc valve, which is commonly used as a heart valve replacement in young children ranging in
ages 5-12 years old [2]. Figure 2.5 displays a description of a Bjork-Shiley tilting disc valve and
Figure 2.6 displays the aortic root model prior to any modifications.
Flange
Inlet Strut
Pyrolytic Carbon
Disc
Suture
Ring

Outlet Strut

Figure 2.5: Bjork-Shiley Convexo Concave Tilting Disc Valve

39	
  
	
  
HV Placement

Sinus
Region

Tubing
Connector

Figure 2.6: Transparent Acrylic Aortic Root Model
In order to accommodate the smaller heart valve in the opening where the 27mm valve
was intended to be placed, an appropriately sized rubber O-ring was attached to the opening
using silicone adhesive. The diameter of the O-ring is slightly larger than the diameter of the
pediatric heart valve (17 mm), however small enough to ensure a tight seal around the valve.
Silicone adhesive was chosen as the method to secure the O-ring to the original model as it is
both transparent and water-resistant, which would allow fluid testing to be conducted without
obstructing flow or the visualization of flow surrounding local regions of the valve. Figure 2.7
displays the O-ring modification used in order to secure the smaller valve in place and the final
assembly.
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Figure 2.7 (Left): O-Ring Modificaton, (Right): Final Assembly
2.2 Ultrasonic Flow Meter
In order to measure the volumetric flow rate and thus calculate the flow velocity, an
ultrasonic flow meter was placed in the loop prior to entrance into the valve holding chamber.
The flow meter used in this study was a H20XL-Sterile Tubing Flow Sensor manufactured by
Transonic Systems Incorporated (TSI). These flow meters are used in a wide variety of
biomedical settings, including artificial heart and VAD performance, medical device testing, and
compliance flow testing [36]. These flow meters are capable of measuring volume flow in most
non-aerated liquids, including saline, and blood and water buffer solutions without making
physical contact to the fluid media [36]. The flow meter functions by clamping around tubing of
specific dimension and employing ultrasonic transit time technology to measure the time
difference of ultrasonic pulses transmitting both in and against the fluid flow direction [36].
Specifically, four transducers within the sensor pass ultrasonic signals intersecting the fluid path
upstream and downstream, and the difference between the four ultrasonic transit times yields a
measurement of volume flow at the particular instant in time. Actual volume flow measurements
are then digitally displayed in mL or L/min, allowing for continuous monitoring of flow
measurements.
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The sensor size of the flow meters are determined by outer tubing diameter, with the
tubing in this research being 1.25” OD. The sensor size that correlates to this tubing diameter is
the H20XL sensor, which has a 50 mL/min resolution, max flow of 100 L/min, and ultrasonic
frequency of 1.2 MHz [36]. Resolution is defined as the smallest detectable flow change at 0.1
Hz filter. Prior to clamping the flow meter on the mock loop tubing, a thin layer of petroleum
jelly was applied to the section of tubing to serve as an acoustic couplant. This layer enables the
ultrasonic transmission between the tube and the sensor. In order to place the flowmeter on the
tubing, the lubricated tubing was placed in the sensing cavity and the lid was closed to ensure a
tight fit. The tubing cross section was “squared off” with the sensor to ensure contact of all
surfaces to the sensing window. Once the tubing was filled with fluid, the flowmeter controls can
be operated to measure volume flow. Data collection began after all visible air bubbles were
absent from the system.
2.3

Blood Analog Mixture
In order to appropriately assess MHV hemodynamic performance, it is imperative to use

a fluid with similar viscous characteristics to human blood. In this study, a mixture of 60% water
and 40% glycerin was used as the blood analog. This particular mixture is widely used in various
mock loop flow visualization studies, as its properties such as density and viscosity closely
match that of natural whole blood. The density of the blood analog results in a value of 1.105
g/mL, whereas the density of natural blood is 1.05 g/mL. The viscosity of the analog has a value
of 0.00485 N-s/m2, whereas natural blood has a viscosity of 0.0027 N-s/m2. As opposed to whole
blood, this mixture presents the advantage of being readily available while not posing safety
concerns associated with blood-borne diseases. This mixture also presents a fluid of Newtonian
characterization, which is also seen in most arteries. By the definition of a Newtonian fluid, both
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the blood analog and whole blood exhibit a linear relationship between shear stress and
deformation rate, and its viscosity can be assumed to be a constant value. Approximately 600 mL
of water and 400 mL of glycerin was used to fill the loop intended for this particular study. The
mixture was prepared in a glass beaker and mixed using a magnetic stirrer prior to implantation
into the loop.
2.4

Particle Image Velocimetry (PIV)
In order to visualize the flow across the valve, Particle Image Velocimetry (PIV) was

utilized in this research to gain insight on the general flow characteristics of the valve. This
technique measures fluid velocity by determining particle displacement over a precisely selected
time [33]. A laser light sheet illuminates a plane within the flow, and the positions of the
illuminated particles in that plane are recorded using a high speed CCD digital camera. A short
duration later, a second image is taken creating a pair of images that can be used to correlate
velocity measurements from displacement of the particles. In addition to velocity information,
other flow properties such as vorticity, strain rates, turbulence intensity, and general flow
structures can be obtained using PIV analysis algorithms embedded in the associated PIV
software. Typical PIV systems consist of both hardware and software components, including a
laser, synchronizer, CCD camera, and computer with the appropriate software. Figure 2.8
displays the general principle behind typical PIV experimental setup.
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Figure 2.8: Typical PIV Setup [33]
2.4.1

Hardware

2.4.1.1 Camera
In order to capture consecutive images of the fluid path across the valve, a high resolution
CCD camera was mounted directly above the valve holding model. The camera was mounted at
an optimal distance from the imaging area such that the images provided high contrast and the
seeded particles could be visible to the naked eye. The camera is able to capture images of the
particles in the fluid path, and digitize the image for further processing on a computer.
Specifically, the camera converts light energy into electrical energy, generating an electrical
signal that is sent to the Frame Grabber installed in the computer [33]. The CCD camera used in
this research was the PIVCAM 10-30 (TSI Incorporated) with a maximum frame rate of 30 Hz,
using a CCD array of 1008 x 1018 pixels. The amount of images taken by the camera is
controlled using the associated Insight software installed on the computer. The particles used in
this research were manufactured by Duke Scientific Corporation, consisting of polymer
microspheres spheres with 100 g/mL density and 100-500 µm mean diameter size. These
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particles are capable of being illuminated when exposed to laser light sheets, allowing for the
camera system to capture their movements within the fluid.
2.4.1.2 Adjustable Laser
The laser light source used in this research was the Altair Series 532nm Green Laser
Pointer manufactured by Laserglow Technologies [35]. This particular laser source was chosen
due to its capability of adjusting beam width and its wavelength value. By controlling the width
of the beam produced by this laser, the flow field surrounding the valve could be properly
illuminated. This laser emits a wavelength of 532 mm, which is frequently seen in typical PIV
setups. The output power of this laser pointer is 4.0-5.0 mW, has a duty cycle of 90 seconds on
and 20 seconds off, and consists of a solid brass casing. This laser was mounted near the valve
chamber along with a beam-splitting lens to allow for illumination of the particles within the
flow field of interest. The laser light sheet was positioned so that its orientation is at a 90 degree
angle to the camera.
2.4.1.3 Computer
The components of the PIV system are controlled and monitored using a Dell Pentium 4
PC with 512 RAM. This particular computer contains a 40 GB hard drive and 1.2 GHz
processing speed. This computer is able to communicate with the camera by utilizing the frame
grabber installed in the computer. The frame grabber reads the image captured from the camera
and displays it as a digital image on the monitor. The digital images are then stored in the RAM
and further processed in the associated Insight 3.2 PIV software installed on the computer.
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2.4.2 Imaging Software
The software utilized in this research consists of the Insight 3G® global imaging,
analysis, and display software produced by TSI. This software is capable of dividing the digital
images captured by the camera into designated interrogation areas within the flow field of
interest. The typical size of an interrogation region is 32 x 32 pixels, however can be altered
within the software [33]. The Insight software allows for the masking of particular regions in the
interrogation region, in order to ignore certain unwanted features in the image and reduce noise.
After the software divides the images into interrogation regions, it then determines the number of
usable particles and their corresponding locations within the two image pairs [33]. Statistical
cross-correlation algorithms within the software are used to determine the displacements of the
particles and therefore their velocities.
2.5 Research Plan
Through the use of the flow meter and the PIV camera setup, volumetric flow rates and
particle images of the valve opening and closing cycles were collected throughout this study.
The flow meter was placed on the tubing right before the entrance to the valve holding chamber,
allowing volumetric flow rates to be taken at that location throughout the different pump
operating conditions. After the flow rates were collected, these values were used to determine
average flow velocities at each given operating condition. A sequence of six particle images
were captured at each operating condition, to allow for the analysis of local flow behavior
during both opening and closing phases of the valve. These images were then post-processed
using Matlab® to enhance image contrast to allow for better visual detection of the particles
embedded within the flow.
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In order to simulate realistic pediatric flow conditions, a specific set of pump operating
conditions were selected. Specifically, heart rate (HR) and stroke volume (SV) were varied
using adjustable controls present on the Harvard Apparatus Pulsatile blood pump. Conditions
for pediatric flow were based on several literature findings [3, 21] and the evidence that
increasing heart rate and decreasing stroke volume and cardiac output is expected for younger
patients. Heart rates tested ranged from 50-100 strokes/min, with the high-end representing
infant patients (1 month- 1 year), and the low-end representing adolescent patients (18+ years).
Stroke volume ranged from 15-85 mL/stroke, and systolic duration was kept constant at 30%.
The theoretical cardiac output of the pump was calculated and compared to the experimental
flow rates the flow meter measured at each operating condition. Table 2.1 displays the pump
operating conditions used to simulate pediatric flow used in this study.

Table 2.1: Pump Operating Conditions for Pediatric Flow

HR	
  
(Strokes/Min)

Stroke	
  Volume	
  
(mL/stroke)

50

85

60

70

70

55

Child	
  (5-‐12	
  yrs)

80

40

Toddler	
  (1-‐4	
  ys)

90

25

Infant	
  (6	
  
months)

100

15

Age	
  

Adolescent	
  (18+	
  	
  
yrs)
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3 RESULTS
The data acquired throughout this study consisted of both flow rate data collected by the
flow meter and sequences of PIV images captured by the CCD camera at each operating
condition. A total of six unique operating conditions were tested, with varying heart rate and
stroke volume combinations. Each operating condition was determined using published pediatric
patient flow data, and corresponds to four different pediatric age groups. Systolic duration was
kept constant at 30%. The flow rate data was collected using a Transonic flow meter and stored
in an Excel file, and then converted to flow velocity values. Flow rate data was initially collected
while heart rate was increasing, and subsequently collected as heart rate was decreasing to
explore possible hysteresis effects. A set of six sequential PIV images were taken at each
operating condition in order to track particle motion throughout opening and closing phases of
the valve. The CCD camera used in this study utilized a 28 mm lens with a 30 Hz frame rate,
denoting a 33.33 ms time separation between each image capture.
3.1 Flow Rate Data
Table 3.1 displays the average experimental flow rate data (L/min) for each operating
condition, with heart rate increasing as data was being collected. The theoretical cardiac output
of the pump is also shown and was calculated as heart rate multiplied by stroke volume, and
compared to the experimental flow rate values. After collecting average flow rate values, average
!×  !"#$  !"#$

flow velocity was also determined using the equation !"#$%&'( =    !  ×!"#$%&  !"#$%&%' where
tubing diameter was 1.25 inches. Table 3.2 also displays the experimental flow rate data for each
operating condition as heart rate was decreasing.

48	
  
	
  

Table 3.1: Flow Rate Data with Increasing HR
HR	
  
(Strokes/Min)

Stroke	
  Volume	
  
(mL/stroke)

Cardiac	
  Output	
  
(L/min)

Flow	
  Rate	
  
(L/min)

Flow	
  Velocity	
  
(m/s)	
  

50

85

4.25

5.005

1.6

60

70

4.2

4.96

1.59

70

55

3.85

4.8

1.54

Child	
  (5-‐12	
  yrs)

80

40

3.2

4.45

1.43

Toddler	
  (1-‐4	
  ys)

90

25

2.25

3.3

1.06

Infant	
  (6	
  
months)

100

15

1.5

2.45

0.79

Age	
  

Adolescent	
  (18+	
  	
  
yrs)

Table 3.2: Flow Rate Data with Decreasing HR
HR	
  
(Strokes/Min)

Stroke	
  Volume	
  
(mL/stroke)

Cardiac	
  Output	
  
(L/min)

Flow	
  Rate	
  
(L/min)

Flow	
  Velocity	
  
(m/s)	
  

50

85

4.25

5.145

1.6

60

70

4.2

5.06

1.59

70

55

3.85

4.985

1.54

Child	
  (5-‐12	
  yrs)

80

40

3.2

4.49

1.43

Toddler	
  (1-‐4	
  ys)

90

25

2.25

3.515

1.06

Infant	
  (6	
  
months)

100

15

1.5

2.534

0.79

Age	
  

Adolescent	
  (18+	
  	
  
yrs)

Figure 3.1 display flow rate versus heart rate for both the theoretical cardiac output of the
pump and the experimental flow rate values. For both increasing and decreasing heart rate
conditions, experimental flow rate values were higher than theoretical CO calculations at each
operating condition. For the increasing heart rate case, the average percent difference between
theoretical and experimental values resulted in a value of 34.9%, with the percent difference
increasing as heart rate increased. For the decreasing heart rate case, the average percent
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difference between theoretical and experimental values resulted in a value of 39.4%, with larger
percent differences at higher heart rates as well. This discrepancy between theoretical cardiac
output and the measured flow rates are most likely attributed to the Harvard Pump not having a
digital read-out as parameters were being adjusted throughout each operating condition.

Figure 3.1: Theoretical CO vs. Experimental Flow Rate
3.2 PIV Images
As mentioned previously, six sequential PIV images were captured at each operating
condition in order to examine the local flow characteristics of the valve. The camera used
operates at a 30 Hz frame rate, denoting a 33.33 ms time separation between each consecutive
image. After image capture and storage, Matlab® was used to convert the RGB images to
grayscale images and also to enhance contrast. By enhancing the contrast of each image, the
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visibility of the illuminated particles was improved. These images were used to make general
conclusions of flow characteristics, such as regions of turbulence or recirculation.

3.2.1 50 BPM at 85 mL Stroke Volume
Figure 3.2: Valve Motion at 50 BPM and 85 mL Stroke Volume
Figure 3.2 shows the six sequential PIV images captured while pump conditions were set
to 50 BPM and 85 Stroke volume, with the valve opening 50 times per minute. The flow meter
measured an average flow rate of 5.005 L/min during these conditions, with an average flow
velocity of 1.6 m/s. Image 1 in the series displays the valve in the fully open position, whereas
image 2-4 show the valve entering the closing phase or diastolic phase of the cardiac cycle.
Images 5 and 6 show the valve entering the opening phase or systolic phase of the cardiac cycle.
Images 2,3, 4 and 6 show evidence of recirculation regions in the local vicinity of the valve.
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3.2.2 60 BPM at 70 mL Stroke Volume
Figure 3.3: Valve Motion at 60 BPM and 70 mL Stroke Volume
Figure 3.3 shows the six sequential PIV images captured while pump conditions were set
to 60 BPM and 70 Stroke volume, with the valve opening 60 times per minute. The flow meter
measured an average flow rate of 4.96 L/min during these conditions, with an average flow
velocity of 1.59 m/s. Image 1-2 in the series displays the valve entering the open or systolic
phase, whereas image 3 show the valve entering the closing phase or diastolic phase of the
cardiac cycle.
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3.2.3 70 BPM at 55 mL Stroke Volume
Figure 3.4: Valve Motion at 70 BPM and 55 mL Stroke Volume
Figure 3.4 shows the six sequential PIV images captured while pump conditions were set
to 70 BPM and 55 Stroke volume, with the valve opening 70 times per minute. The flow meter
measured an average flow rate of 4.8 L/min during these conditions, with an average flow
velocity of 1.54 m/s. Images 1-3 display the valve entering the closing phase or diastolic phase of
the cardiac cycle, whereas images 4-5 show the valve during the opening phase.
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3.2.4 80 BPM at 40 mL Stroke Volume
Figure 3.5: Valve Motion at 80 BPM and 40 mL Stroke Volume
Figure 3.5 shows the six sequential PIV images captured while pump conditions were set
to 80 BPM and 40 Stroke volume, with the valve opening 80 times per minute. The flow meter
measured an average flow rate of 4.45 L/min during these conditions, with an average flow
velocity of 1.43 m/s. Image 1 displays the valve in the closed position, whereas images 2,4, and 6
show the valve entering the opening or systolic phase.
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3.2.5 90 BPM at 25 mL Stroke Volume
Figure 3.6: Valve Motion at 90 BPM and 25 mL Stroke Volume
Figure 3.6 shows the six sequential PIV images captured while pump conditions were set
to 90 BPM and 25 Stroke volume, with the valve opening 90 times per minute. The flow meter
measured an average flow rate of 3.3 L/min during these conditions, with an average flow
velocity of 1.06 m/s. Images 1-2 show the valve entering the opening or systolic phase whereas
Image 3 show the valve entering the closing phase.
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3.2.6 100 BPM at 15 mL Stroke Volume
Figure 3.7: Valve Motion at 100 BPM and 15 mL Stroke Volume
Figure 3.7 shows the six sequential PIV images captured while pump conditions were set
to 100 BPM and 15 Stroke volume, with the valve opening 100 times per minute. The flow meter
measured an average flow rate of 2.45 L/min during these conditions, with an average flow
velocity of 0.79 m/s. Images 1-2 show the valve entering the opening phase, whereas images 3
and 5 show the valve entering closing phase.
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4

DICUSSION
This experimental study evaluated the performance of a pediatric-sized tilting disk heart

valve under six unique operating conditions, while measuring flow rates and capturing sequential
PIV images of the opening and closing phases of the valve. Through the use of the adjustable
Harvard Apparatus Pulsatile Blood Pump, six different pediatric flow conditions were tested by
altering both heart rate and stroke volume produced by the pump. The six different heart rate and
stroke volume combinations were as followed: 1. 50 BPM, 85 mL, 2. 60 BPM, 70 mL, 3. 70
BPM, 55 mL, 4. 80 BPM, 40 mL, 5. 90 BPM, 25 mL, and 6. 100 BPM, 15 mL. These heart rate
and stroke volume values were selected in order to accurately simulate heart flow conditions for
younger patients. The systolic duration of the pump was kept constant at 30% of the cycle length.
The fluid used in this experiment consisted of a water/glycerin mixture, in order to simulate
similar fluid properties as whole blood such as viscosity and density. This experiment helps to
evaluate and assess the performance of a pediatric sized heart valve within the mock loop
experimental set up, which may eventually lead to the progression of knowledge regarding the
performance and in-vitro testing procedures of pediatric heart valves.
4.1 Flow Rate Data
Through the use of an ultrasonic flow meter, flow rate data was collected prior to the
entrance of the heart valve testing chamber. The average flow rates were recorded for each pump
operating condition, and used to convert values into average flow velocities. Flow data was
recorded for two different scenarios, one being as heart rate was increasing (operating conditions
1 to 6) and one being as heart rate was decreasing (operating conditions 6 to 1). For both cases,
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flow rate and thus flow velocities decreased as heart rate increased and stroke volume decreased.
This result was anticipated, as younger patients produce lower cardiac outputs due to increased
heart rate but decreased stroke volume. This can be explained due to younger myocardium being
physiologically different to that of adult or maturing myocardium. Myocardium is the muscle
wall of the heart, which is responsible for contracting in order to pump blood out of the heart and
relaxing to allow the heart to fill with blood. The myocardium of younger patients, specifically
newborns, contains less contractile fibers than that of the adult heart. Due to having less
contractile power, younger patients are not able to produce similar cardiac outputs as adults. In
addition, adult hearts are able to increase its stroke volume by both strengthening contractions
and increasing heart rate. In contrast, the pediatric heart can only increase stroke volume by
increasing heart rate. Structurally, children have smaller heart chambers and lower overall blood
volume than the adult heart, therefore lower cardiac outputs are expected for younger patients.
The flow rate values collected during this study support this, as flow rate consistently decreased
with increasing heart rate, as the higher heart rate conditions represent younger patient flow
conditions. This flow data also shows the capability of the mock circulatory loop in simulating
accurate pediatric flow conditions for the testing of a pediatric sized MHV.
The flow rate data collected during this study was also compared to the theoretical
cardiac output of the Harvard pump. For both testing scenarios, the measured flow rates were
slightly higher than the associated theoretical cardiac outputs. In addition, the percent difference
between measured flow and theoretical output increased significantly as heart rate increased.
This difference between measured flow values and the theoretical output of the pump can be
attributed to several factors including slight variations of fluid viscosity and density, flow meter
sensitivities, and pump inaccuracies. Several times throughout this experiment, small amounts of
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water were added to the loop to reduce the presence of air bubbles trapped within the loop. By
adding small amounts of water to the loop, the viscosity of the overall water/glycerin mixture
may have decreased slightly, resulting in the higher measured flow rates. In addition, flow meter
sensitivities may also have contributed to the higher measured flow rate values. Inconsistences
such as slight fluctuations in temperature or a non-uniform Vaseline seal between the tubing and
the sensor could have attributed to this error. The most significant changes in the uniformity of
the ultrasonic beam used in the sensor occur at either the tubing/sensor interface or the
tubing/liquid border. In addition, the manual adjustments of the pump for both heart rate and
stroke volume do not have digital read-outs, therefore actual pump parameters may have been
slightly different from the intended operating condition.
The purpose of collecting data during two different scenarios, one being as heart rate was
increasing, and the other being as heart rate was decreasing, was to explore any possible
hysteresis effects present within the fluid or equipment. Specifically, the intent was to investigate
if the measured flow rates would differ as heart rate was being approached at either the high or
low limits. The results indicated that flow rates were not significantly affected as heart rate was
being increased or decreased, indicating little hysteresis effects. However, flow rates were
slightly higher in the case where heart rate was being decreased from the highest value to the
lowest. This may be attributed to the fact that the pump had to go through the lower heart rates
prior to reaching the highest value starting point.
4.2 PIV Images
During this study, sequential PIV images were taken at each operating condition to verify
proper valve mechanical functionality as well to determine flow characteristics of the opening
and closing phases of the valve. In order to visually observe the flow characteristics, particle
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illumination and MATLAB post-processing was used in order to increase the contrast between
the particles and the background. These images were used to generate qualitative information
regarding the structure of the flow, and regions of flow stagnation and recirculation. Such
information is useful in the assessment of the valve performance as it relates to clinical
complications such as thrombosis and hemolysis.
4.2.1 Opening Phase of Valve (Systole)
During the opening phase of the valve, the images collected display certain flow
characteristics that are typical of a tilting disc valve, such as producing a major and minor
outflow region. The major and minor flow regions are produced by the 60 degree tilt of the disc
when in the fully opened position during systole. The major outflow jet is characterized by being
larger spatially and well as appearing to have higher local velocity, and thus likely producing
higher shear stresses in this region. The minor outflow region is smaller, with lower local
velocities and likely more dispersed stresses.
As heart rate increases and stroke volume decreases, average flow velocities during the
open phase of the valve decrease. Specifically, flow velocities of approximately 1.6 m/s were
achieved during the first operating condition (50 BPM, 85 mL), whereas flow velocities as low
as 0.79 m/s were recorded during the last operating condition (100 BPM, 15 mL). This is
visually evident in the images captured during the opening phases of the valves at each condition
by examining the particle motion. Specifically, lower heart rates showed more streamlined,
laminar flow and higher heart rates showed more disorganized, random forward flow during the
open phase. This may be attributed to the higher heart rate conditions having less time for the
fluid flow to fully develop, as well as the decreased stroke volume per beat. The disorganized,
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slower forward flow seen with the higher heart rate conditions may lead to regions of potential
flow stagnation under such flow conditions.
4.2.2 Closing Phase of Valve (Diastole)
Certain flow characteristics during the closing phase of the valve were also evident in the
sequences of PIV images collected. For instance, a small degree of retrograde flow can be seen
in the images just before valve closure. These instances of retrograde flow coincide with the
Harvard pump’s diastolic phase, which is dominated by the motor’s drawback mechanisms.
Regions of regurgitant and swirling flow are also evident throughout the valve’s closing phase
during each operating condition, specifically right after valve closure. By examining the images
at each operating condition, these regions of swirling regurgitant flow seem to dissipate as heart
rate increased. This may be attributed to the higher heart rate conditions having less time spent in
the diastolic or drawback phase of the Harvard pump. With less time spent in the diastolic phase,
less backflow can occur and the magnitude of the swirling regions seems to decrease. The largest
amount of recirculating, swirling flow occurs when the operating conditions were set to 50 BPM
and 85 mL stroke volume, whereas the least amount of swirling occurring at 100 BPM and 15
mL. This suggests that heart rate has a significant effect on regurgitant volume during the closing
phase of a pediatric sized tilting disc valve.
The location and structure of the swirling flow regions varies throughout the different
operating conditions tested. The two operating conditions that displayed the most prominent
amount of recirculation during the closing phase were the two conditions with the lowest heart
rates; 50 BPM and 85 mL stroke volume and 60 BPM and 70 mL stroke volume. The operating
condition with 50 BPM and 85 mL stroke volume appeared to develop a region of recirculation
in the major orifice region near the edge of the leaflet at the beginning of valve closure. After
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complete valve closure, the swirling region appears to travel downstream the valve, growing
larger and translating more to the mid-line of the fluid path. This may be attributed to the valve
holding chamber producing minimal compliance at the time of occluder impact, accentuating
recirculation in the local vicinity of the valve. Figure 4.1 displays two images captured during
the closing phase at the 50 BPM and 85 mL operating condition, with the circled regions being
were the most prominent recirculating regions occur.

Figure 4.1: Regions of Recirculation with 50 BPM and 85 mL SV
The operating condition with the second lowest HR (60 BPM and 70 mL) also displayed regions
of recirculation during the valve closing phase. However this set of images showed a
recirculating region appearing in the minor orifice region at the tip of the valve leaflet during
valve closure. This recirculating region at the tip of the leaflet may lead to the development of a
vortex structure, which makes this region susceptible to potential cavitation. Once the valve was
fully closed, recirculation regions were apparent in the lower bulging sinus region of the valve
testing chamber. Pockets of recirculating flow in this bulging sinus region can be attributed to
this region acting as a reservoir-type structure during the diastolic phase of the Harvard pump.
Figure 4.2 displays these regions of recirculation during valve closure at 60 BPM and 70 mL.
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Figure 4.2: Regions of Recirculation at 60 BPM and 70 mL SV
As mentioned previously, these images suggest more swirling regions occur during valve
closure in the lower heart rate cases, the operating conditions intended to simulate older patient
flow conditions. This suggests that as the patient ages, these regurgitant regions may lead to
clinical complications such as thrombotic or hemolytic activity. Although significant regurgitant
or swirling regions may have adverse long term effects, a small degree of retrograde flow in
tilting disc valves is advantageous and expected. This small degree of retrograde flow is capable
of producing a washout effect between the disc and the housing of the valve, washing away any
thrombus formations.
Possible Future Progression
The Artificial Heart Laboratory at Virginia Commonwealth University is constantly
seeking to make improvements and advancements in mock circulatory loop testing in regards to
mechanical heart valve evaluation. Possible future progression in terms of mock loop testing may
include the incorporation of additional loop components to provide a more accurate
physiological environment. Such components may include variable resistors to simulate arterial
and peripheral resistance, as well as additional capacitors to simulate ventricular compliance.
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Such components were excluded in this research because the primary focus of this study was the
investigation of local valve fluid behavior, with less emphasis on mock loop performance. Such
mock loop improvements will further expand the scope of mechanical heart valve testing in the
future.
In addition, the testing and evaluating of different pediatric valves could provide a larger
breadth of knowledge regarding the performance of pediatric valves in experimental settings. As
an example, the testing of a pediatric-sized bileaflet valve would allow for the comparison
between bileaflet and tilting disc valve performance. The testing of a variety of different sized
pediatric valves would also be beneficial as it would allow for the comparison of flow behavior
across a multitude of valve sizes. A heart valve testing chamber capable of holding a range of
valve sizes could facilitate such testing in the future. By doing so, more conclusive data could be
collected regarding the performance of pediatric valves under experimental conditions.
Conclusions
With congenital heart valve disease being among one of the most common heart defects
found in the pediatric population, the testing and evaluation of pediatric sized mechanical heart
valves is imperative to the development of such valves. As there are currently no FDA approved
mechanical heart valves available for the use in pediatric patients, it is necessary to develop
standard in-vitro testing procedures in order to gain a better understanding of the fluid mechanics
associated with smaller sized heart valves. The research presented here describes the
development of an in-vitro experimental set-up that is capable of evaluating the functionality of a
pediatric-sized tilting disc valve, a common valve chosen for implantation in pediatric patients.
The experimentation involved the incorporation of a mechanical heart valve testing chamber into
a mock circulatory loop that is capable of simulating a wide range of cardiovascular
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physiological conditions. Specifically, the Harvard Apparatus Pulsatile pump was used in this
research to simulate pre-determined pediatric flow conditions, by altering both the heart rate and
stroke volume produced by the pump. A set of six unique pump operating conditions were
chosen to model pediatric flow, ranging from 6 months of age to 18+ years. Through the use of
fluid flow visualization techniques and flow rate measurement, specific flow characteristics were
observed during both the opening and closing phases of the valve. The results from this study
indicated a decrease in flow rate and velocity as heart rate was increased, which is expected in
younger patients. In addition, the lower heart rate conditions displayed more of a streamlined,
laminar flow during the open phase, whereas the higher heart rates displayed a more
disorganized, random forward flow. During the closing phase of the valve, more regions of
recirculating, swirling flow were seen in the lower heart rate conditions. Specifically, the major
regions of recirculation included the regions surrounding the tip of the valve leaflet. These
regions of swirling flow may lead to the development of potential clinical complications such as
thrombosis and cavitation. By characterizing the general flow behavior of this pediatric-sized
mechanical heart valve, this study may aide in the design and development of additional
mechanical heart valves intended for the pediatric population. Localized design changes such as
altering the shape of the leaflet edge, may contribute to more positive fluid mechanics behavior
specifically during valve closure.
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APPENDIX

MATLAB Code used to increase contrast of PIV images:
>> RGB1= imread ('con61.jpg');
A = rgb2gray(RGB1);
A_imadjust=imadjust(A);
RGB2= imread ('con62.jpg');
B = rgb2gray(RGB2);
B_imadjust=imadjust(B);
RGB3= imread ('con63.jpg');
C = rgb2gray(RGB3);
C_imadjust=imadjust(C);
RGB4= imread ('con64.jpg');
D = rgb2gray(RGB4);
D_imadjust=imadjust(D);
RGB5= imread ('con65.jpg');
E = rgb2gray(RGB5);
E_imadjust=imadjust(E);
RGB6= imread ('con66.jpg');
F = rgb2gray(RGB6);
F_imadjust = imadjust(F);
figure,imshow(A_imadjust)
Figure, imshow (B_imadjust)
Figure, imshow (C_imadjust)
Figure, imshow (D_imadjust)
Figure, imshow (E_imadjust)
Figure, imshow (F_imadjust)

>> % Code used to increase contrast of PIV Images
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